No photo of Ole Weiss Bjerrum

Ole Weiss Bjerrum

20182019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Conference abstract for conference
2018

Interferon-alfa2 Treatment of Patients with Polycythemia Vera and Related Neoplasms Impacts Deregulation of Oxidative Stress Genes and Antioxidative Defence Mechanisms. Potential Implications of IFN-Alfa Induced Changes in TP53, NRF2 and CXCR4 for Genomic Instability and CD34+ Mobilisation.

Skov, V., Riley, C. H., Thomassen, M., Kjær, L., Larsen, T. S., Weiss Bjerrum, O., Kruse, T. A. & Hasselbalch, H. C., 3. Dec 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.

Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V. H., Stentoft, J., Starklint, J., de Stricker, K., Thomassen, M., Larsen, T. S. & Hasselbalch, H. C., 15. Jun 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial.

Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V., Stentoft, J., Starklint, J., de Stricker, K., Thomassen, M., Larsen, T. S. & 2 others, Hasselbalch, H. C. & Hasselbalch, H. C., 3. Dec 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

Mikkelsen, S. U., Kjær, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Skov, V., Andersen, C. B. L., Weiss Bjerrum, O., Brochmann Mortensen, N., El Fassi, D., Kruse, T., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, C. H., Pallisgaard, N., Thomassen, M. & Hasselbalch, H. C., 15. Jun 2018.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review